US2010172967A1PendingUtilityA1

Compound modified with glycerol derivative

Assignee: KYOWA HAKKO KIRIN CO LTDPriority: Sep 3, 2003Filed: Feb 19, 2010Published: Jul 8, 2010
Est. expirySep 3, 2023(expired)· nominal 20-yr term from priority
C07D 207/452C07K 5/0202C07C 323/60C07F 9/10A61K 47/54A61K 47/00B82Y 5/00A61K 47/6911C07K 5/02C07K 5/08
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Objects of the present invention are to provide a compound which is useful as a surface modifier for producing a drug carrier or the like, or a salt thereof; a fine particle comprising the same; and the like. The present invention provides a compound in which a substance to be modified, which is selected from the group consisting of an amphiphilic substance and a hydrophobic substance, is modified with a glycerol derivative represented by the following formula (1): wherein R represents a residue comprising a reactive group for the substance to be modified, which is selected from the group consisting of an amphiphilic substance and a hydrophobic substance or for a spacer capable of binding the substance to be modified, which is selected from the group consisting of an amphiphilic substance and a hydrophobic substance, to R—X, or a group capable of being transformed into the reactive group; n represents an integer of 3 or more; and X represents a residue capable of having the following structure by n in number: directly or via the spacer, or a salt thereof; a fine particle comprising the same; and the like.

Claims

exact text as granted — not AI-modified
1 - 28 . (canceled) 
     
     
         29 . A compound comprising (i) a substance selected from the group consisting of phospholipid, glyceroglycolipid, sphingoglycolipid, sphingoids, sterols, cationic lipid, anionic lipid, polyhydric alcohol ester nonionic surfactant, anionic surfactant, cationic surfactant, ampholytic surfactant, liquid paraffin, vegetable oil, ester of fatty acid having 12 to 30 carbon atoms, castor oil, polyoxyethylene castor oil, lanolin, polyaspartic acids, poly(β-benzyl aspartate), poly(γ-benzyl glutamate), poly(β-alkyl aspartate), polylactide, poly(ε-caprolactone), poly(δ-valerolactone), poly(γ-butyrolactone), poly(β-benzyl aspartate-co-aspartic acid), poly(γ-benzyl glutamate-co-glutaminic acid) and poly(α-amino acid), linked directly or via a spacer with (ii) a group represented by 
       
         
           
           
               
               
           
         
         wherein R 4  represent alkylene having 1 to 10 carbon atoms; and 
         the spacer is a straight-chain linking group selected from the group consisting of substituted or unsubstituted alkylene, carbonyl, substituted or unsubstituted imino, O, S and any combination thereof, 
         or a salt thereof. 
       
     
     
         30 . The compound according to  claim 29 , which is represented by formula (2): 
       
         
           
           
               
               
           
         
         wherein X represents a hydrogen atom or an alkaline metal atom; 
         R 1  and R 2  independently represent a hydrogen atom, a straight chain or branched chain saturated fatty acid residue having an acyl moiety of 12 to 30 carbon atoms or a straight chain or branched chain unsaturated fatty acid residue having an acyl moiety of 12 to 30 carbon atoms, wherein at least one of R 1  and R 2  is the saturated fatty acid residue or the unsaturated fatty acid residue; and 
         R 3  and R 4  independently represent alkylene having 1 to 10 carbon atoms, 
         or a salt thereof. 
       
     
     
         31 . The compound according to  claim 29 , which is represented by formula (4): 
       
         
           
           
               
               
           
         
         wherein X represents a hydrogen atom or an alkaline metal atom; 
         R 1  and R 2  independently represent a hydrogen atom, a straight chain or branched chain saturated fatty acid residue having an acyl moiety of 12 to 30 carbon atoms or a straight chain or branched chain unsaturated fatty acid residue having an acyl moiety of 12 to 30 carbon atoms, wherein at least one of R 1  and R 2  is the saturated fatty acid residue or the unsaturated fatty acid residue; and 
         R 3  and R 4  independently represent alkylene having 1 to 10 carbon atoms, 
         or a salt thereof. 
       
     
     
         32 . The compound according to  claim 30 , wherein R 3  and R 4  are ethylene. 
     
     
         33 . The compound according to  claim 31 , wherein R 3  and R 4  are ethylene. 
     
     
         34 . A fine particle comprising a compound of  claim 29  or said salt thereof. 
     
     
         35 . A fine particle comprising a compound of  claim 30  or said salt thereof. 
     
     
         36 . A fine particle comprising a compound of  claim 31  or said salt thereof. 
     
     
         37 . The fine particle according to  claim 34 , wherein the fine particle is selected from the group consisting of a liposome, a fat emulsion, an emulsion, a micell and a fine particle crystal. 
     
     
         38 . The fine particle according to  claim 35 , wherein the fine particle is selected from the group consisting of a liposome, a fat emulsion, an emulsion, a micell and a fine particle crystal. 
     
     
         39 . The fine particle according to  claim 36 , wherein the fine particle is selected from the group consisting of a liposome, a fat emulsion, an emulsion, a micell and a fine particle crystal.

Join the waitlist — get patent alerts

Track US2010172967A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.